Plazomicin Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Plazomicin is a parenterally administered, broad spectrum aminoglycoside antibiotic typically used for moderate-to-severe urinary tract infections or pyelonephritis.Plazomicin Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Plazomicin Nitroso Impurity 1 CAS NO:NA Chemically represented as (S)-4-amino-N-((1R,2S,3S,4R,5S)-5-amino-4-(((2S,3R)-3-amino-6-(((2-hydroxyethyl)amino)methyl)-3,4-dihydro-2H-pyran-2-yl)oxy)-2-(((2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methyl(nitroso)amino)tetrahydro-2H-pyran-2-yl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide. Synchemia is the leading manufacturing and exporter of Plazomicin Nitroso Impurity 1. We supply Plazomicin Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0142099 |
| CAS No | NA |
| Mol.F. | C14H21N3O4 |
| Mol.Wt. | 295.34 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142100 |
| CAS No | NA |
| Mol.F. | C16H25N3O4 |
| Mol.Wt. | 323.39 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142101 |
| CAS No | NA |
| Mol.F. | C15H20N2O6 |
| Mol.Wt. | 324.33 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142102 |
| CAS No | NA |
| Mol.F. | C33H46N4O9 |
| Mol.Wt. | 642.75 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142103 |
| CAS No | NA |
| Mol.F. | C27H33N3O8 |
| Mol.Wt. | 527.57 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142104 |
| CAS No | NA |
| Mol.F. | C17H25N3O5 |
| Mol.Wt. | 351.40 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142105 |
| CAS No | NA |
| Mol.F. | C17H25N3O5 |
| Mol.Wt. | 351.40 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142106 |
| CAS No | NA |
| Mol.F. | C20H31N3O5 |
| Mol.Wt. | 393.48 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142107 |
| CAS No | NA |
| Mol.F. | C14H10Cl2N2O3 |
| Mol.Wt. | 325.15 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142108 |
| CAS No | NA |
| Mol.F. | C15H12Cl2N2O3 |
| Mol.Wt. | 339.17 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142109 |
| CAS No | NA |
| Mol.F. | C16H14Cl2N2O3 |
| Mol.Wt. | 353.20 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142110 |
| CAS No | NA |
| Mol.F. | C17H14Cl2N2O5 |
| Mol.Wt. | 397.21 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142111 |
| CAS No | NA |
| Mol.F. | C18H16Cl2NO5 |
| Mol.Wt. | 411.24 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142112 |
| CAS No | NA |
| Mol.F. | C23H18Cl2N2O5 |
| Mol.Wt. | 473.31g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142113 |
| CAS No | NA |
| Mol.F. | C18H14Cl2N2O7 |
| Mol.Wt. | 441.22 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142114 |
| CAS No | NA |
| Mol.F. | C20H16Cl2N2O9 |
| Mol.Wt. | 499.25 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |